Holen Sie sich die Stockscreener-App
21.27
2.70%
0.56
Handel nachbörslich:
21.27
Privia Health Group Inc Aktie (PRVA) Neueste Nachrichten
Sentiment analysis tools applied to Privia Health Group Inc.July 2025 PostEarnings & Consistent Profit Focused Trading Strategies - Newser
Is Privia Health Group Inc. building a consolidation base2025 Analyst Calls & Momentum Based Trading Signals - Newser
We Think Privia Health Group's (NASDAQ:PRVA) Healthy Earnings Might Be Conservative - simplywall.st
Statistical indicators supporting Privia Health Group Inc.’s strengthOptions Play & Free Community Supported Trade Ideas - Newser
What recovery options are there for Privia Health Group Inc.Weekly Trading Summary & Community Verified Trade Signals - Newser
News impact scoring models applied to Privia Health Group Inc.Rate Cut & Weekly High Potential Stock Alerts - Newser
Privia Health Group Inc. stock prediction for this weekMarket Volume Summary & AI Enhanced Trading Alerts - Newser
Detecting price anomalies in Privia Health Group Inc. with AITrade Volume Summary & High Conviction Buy Zone Alerts - Newser
Privia Health Group (PRVA) Is Up 6.3% After Raising Full-Year Revenue Outlook—Has the Bull Case Changed? - simplywall.st
5 Must-Read Analyst Questions From Privia Health’s Q2 Earnings Call - Yahoo Finance
Privia Health’s SWOT analysis: capital-efficient model drives stock growth - Investing.com
Privia Health Group Inc. stock daily chart insightsWeekly Profit Report & Detailed Earnings Play Strategies - Newser
Piper Sandler Has Lowered Expectations for Privia Health Group (NASDAQ:PRVA) Stock Price - Defense World
Privia Health’s Earnings Call Highlights Robust Growth - TipRanks
Will Privia Health Group Inc. see short term momentum2025 Retail Activity & Target Return Focused Stock Picks - Newser
Truist Financial Maintains Privia Health(PRVA.US) With Buy Rating, Announces Target Price $30 - 富途牛牛
Barclays Maintains Hold Rating for Privia Health Group with $21 Target - AInvest
Undervalued Stocks for Investment: U.S. Market Fluctuations and Discounts Up to 48.8% - AInvest
3 Stocks Estimated To Be Trading At Discounts Up To 48.8% - Yahoo Finance
Privia Health Group (PRVA) Gets a Buy from Piper Sandler - The Globe and Mail
Natixis Advisors LLC Buys 2,342 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
PRVA Q2 Deep Dive: Platform Growth, Provider Expansion, and Margin Stability Drive Outperformance - Yahoo Finance
Key metrics from Privia Health Group Inc.’s quarterly dataTechnical Entry Plan with Risk Minimization - Newser
Piper Sandler Maintains Privia Health(PRVA.US) With Buy Rating, Cuts Target Price to $35 - 富途牛牛
Piper Sandler lowers Privia Health stock price target to $35 from $36 - Investing.com Nigeria
Privia Health: Piper Sandler maintains Overweight with PT down to $35 from $36. - AInvest
Cetera Investment Advisers Acquires 2,338 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Volume Surge May Signal Institutional Interest in Privia Health Group Inc.Weekly Stock Opportunity Radar Scanner Activated - beatles.ru
Privia Health Group shares rise 5.33% intraday after Q2 2025 earnings call. - AInvest
Privia Health Group Maintains Buy Rating and $32 Price Target - AInvest
Privia Health Group Stocks Surge Amid Strong Q2 Results - TipRanks
Privia Health Group: Strong Performance and Promising Outlook Justify Buy Rating - TipRanks
Privia Health: Q2 Earnings Snapshot - Greenwich Time
Avantax Advisory Services Inc. Boosts Stake in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health raises 2025 outlook above prior range as implemented providers climb 13.8% and value-based lives grow 15.2% - MSN
Privia Health Reports Strong Q2 2025 Financial Results - TipRanks
Privia Health's Q2 2025 Earnings: Navigating Earnings Disappointments While Fueling Sustainable Growth - AInvest
Transcript : Privia Health Group, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Privia Health Group: Strong Buy Rating Backed by Robust Financial Performance and Strategic Expansion - TipRanks
Privia Health shares rise 2.10% after-hours after reporting Q2 revenue of $521.2M, beating estimates. - AInvest
Privia Health (NASDAQ:PRVA) Reports Upbeat Q2 - Yahoo Finance
Privia Health Group shares fall 2.25% intraday after missing Q2 earnings expectations. - AInvest
Privia Health Group Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: Privia Health Q2 2025 misses EPS expectations By Investing.com - Investing.com South Africa
Earnings call transcript: Privia Health Q2 2025 misses EPS expectations - Investing.com
Compared to Estimates, Privia Health (PRVA) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
Privia Health Group, Inc. SEC 10-Q Report - TradingView
Privia Health Group earnings missed by $0.03, revenue topped estimates - Investing.com Canada
Privia Health (PRVA) Misses Q2 Earnings Estimates - Yahoo Finance
Privia Health Group Stocks Surge on Strong Outlook - TipRanks
Privia Health Q2 2025 slides: Strong growth and raised guidance, but shares plunge - Investing.com
Privia Health Q2 revenue misses estimates - MarketScreener
Privia Health Reports Second Quarter 2025 Financial Results - The Manila Times
Privia Health Reports Second Quarter 2025 Financial Results - GlobeNewswire Inc.
Strategies to average down on Privia Health Group Inc.Daily Exit and Entry Price Prediction - Newser
How to use Fibonacci retracement on Privia Health Group Inc.Free Access to Real-Time Trade Insights - Newser
Will Privia Health Group Inc. bounce back from current supportFree High Growth Low Risk Stock Selection - Newser
Custom watchlist performance reports with Privia Health Group Inc.Growth Projection Summary for Long-Term Investors - Newser
Why Privia Health Group Inc. is moving todayTrend Reversal Probability Forecast Update - Newser
7.48%
3.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):